For Primary Care Physicians
Whitney Health · Specialist-level brain health evaluation for your patients. Your job is to refer.
Whitney Health brings comprehensive neuropsychological assessment — the kind that has historically required a specialist referral, a long waitlist, and weeks of turnaround — into your primary care practice. You order it. We deliver it. Your patient receives a neuropsychologist-authored report within 48 hours.
Your Role Is Simple
Log in to Whitney Health — or have your staff do it. Enter the patient’s name and email. Select a service line. You’re done.
Whitney Health handles consent, intake, scheduling, supervision, scoring, annotation, and neuropsychological review. When the report is ready, you receive a notification. Open the report in your Whitney Health dashboard or EHR and act on it.
No clinical training. No new workflow. No specialist coordination. Two minutes of work.
Two Service Lines for Your Patients
Annual Screen
Fulfills the Medicare Annual Wellness Visit cognitive assessment requirement. Patient completes a validated subjective cognitive decline questionnaire — self-administered, no technician, no supervision required. If the patient endorses cognitive concerns, they are automatically routed to a full MCI Assessment. If not, they complete a brief automated screen. Low cost. High scale. No burden on your staff.
MCI Assessment
For patients with reported memory concerns, word-finding difficulty, attentional changes, or family-reported cognitive change. A complete structured intake, supervised assessment, neuropsychologist review, and clinical report — delivered to your dashboard and EHR within 48 hours. Includes a neuropsychologist follow-up telehealth visit with the patient to deliver results and develop a care plan.
What You Receive
A complete neuropsychologist-authored clinical report — not a digital score, not a dashboard flag. A clinical document you can put in the chart, act on, and bill against.
The report includes:
01
Differential diagnostic interpretation across MCI subtypes and late-life depression
02
Performance results across cognitive domains: memory, attention, executive function, processing speed, language, motor function, and mood
03
Normative comparisons and disease likelihood indices
04
Recommended care plan
05
Neuropsychologist contact and sign-off
Why This Matters Now
FDA-approved anti-amyloid therapies — lecanemab, donanemab — are now available for patients with amnestic MCI. But they carry significant risk if prescribed to patients with non-amnestic presentations or late-life depression. Your patients need an accurate differential diagnosis before any treatment decision. Whitney Health provides it.
A brief cognitive screen cannot distinguish amnestic MCI from non-amnestic MCI from late-life depression. Whitney Health can — within a single session, with AUROC performance of 0.94–0.97 against gold-standard neuropsychological reference batteries.
Longitudinal Monitoring
Once a diagnosis is established, Whitney Health tracks your patient’s cognitive and functional status over time — across medications, lifestyle interventions, and disease progression. You receive alerts if the platform detects a concerning change pattern between visits. You assign follow-up assessments through the platform; we handle everything else.
For ACO and Medicare Advantage practices, Whitney Health’s annual monitoring service generates the structured clinical encounter required to recapture MCI as an HCC diagnosis each calendar year — protecting your RAF scores and preventing revenue leakage.
Getting Started
Your administrator registers your practice for a Whitney Health account and configures delivery preferences during onboarding. As a referring physician, you need no formal training — a single how-to reference page covers ordering an assessment and reviewing results. Most practices are live within a few weeks of account setup.
Whitney Health is a product of Kainoa Labs, Inc.